Pfizer/BioNTech jab safe for children aged five to 11
Published
The positive trial results could pave the way for vaccinating children younger than 12, if approved.
Full ArticlePublished
The positive trial results could pave the way for vaccinating children younger than 12, if approved.
Full ArticlePfizer is already working on making sure the jab is safe for children as young as five